Intravitreal Ranibizumab With Panretinal Photocoagulation Followed by Trabeculectomy Versus Visco-Trabeculotomy in Management of Neovascular Glaucoma

Overview

Journal Asia Pac J Ophthalmol (Phila)

Specialty Ophthalmology

Date 2019 Aug 2

PMID 31369406

Citations 3

Authors

Ahmed S Elwehidy

Nader Hussein Lotfy Bayoumi

Amani E Badawi

Sherein M Hagras

Amr Abdelkader

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of the current study was to compare visco-trabeculotomy (VT) with standard trabeculectomy with mitomycin C (Trab-MMC) in the treatment of quiescent neovascular glaucoma (NVG).

Methods: The study was conducted on 51 eyes of 51 patients presenting with NVG and treated at an Ophthalmic Center in Egypt between March 2014 and April 2017. All study eyes were subjected to a standard protocol of intravitreal injection of ranibizumab followed by panretinal photocoagulation. Eyes were then randomized to either VT or Trab-MMC. Study eyes were followed up for at least 18 months. Success was defined as an intraocular pressure of ≤21 mm Hg and without vision-threatening complications. Complications were noted.

Results: The mean ± SD (range, median) age of the study patients was 54.1 ± 6.4 (40-67, 54.5) and 52.4 ± 8.8 (38-66, 53) years in the VT (26 eyes) and Trab-MMC (25 eyes) groups, respectively (P = 0.45). The mean ± SD (range, median) intraocular pressure (IOP) of the study eyes was 45.19 ± 2.97 (39-52, 45.5) and 45.64 ± 3.56 (3-53, 45) mm Hg on maximal medical therapy in the VT and Trab-MMC groups, respectively (P = 0.61). At 18 months' follow-up, the mean ± SD (range, median) IOP of the study eyes was 18.19 ± 2.0 (16-23, 17) and 19.92 ± 2.6 (18-26, 19) mm Hg in the VT and Trab-MMC groups, respectively (P = 0.004). There was no difference in postoperative antiglaucoma medication between the 2 groups (P = 0.62). Complications included hyphema and Descemet split in the VT group and an IOP spike in the Trab-MMC group. Success rates were 84.6% and 80% in the VT and Trab-MMC groups, respectively (P = 0.726).

Conclusions: Both VT and Trab-MMC groups are effective in reducing the IOP in cases of NVG after control of neovascularization with anti-vascular endothelial growth factor and pan retinal photocoagulation.

Citing Articles

Anti-vascular endothelial growth factor for neovascular glaucoma.

Rittiphairoj T, Roberti G, Michelessi M Cochrane Database Syst Rev. 2023; 4:CD007920.

PMID: 37010901 PMC: 10069372. DOI: 10.1002/14651858.CD007920.pub4.

23G Minimally Invasive Vitrectomy Combined with Glaucoma Drainage Valve Implantation and Phacoemulsification Cataract Extraction for Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.

Shi X, Dong N, Liang Y, Zheng L, Wang X Comput Math Methods Med. 2022; 2022:7393661.

PMID: 35966245 PMC: 9371887. DOI: 10.1155/2022/7393661.

Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma.

Zhao X, Wang Y Evid Based Complement Alternat Med. 2022; 2022:4127293.

PMID: 35958912 PMC: 9359820. DOI: 10.1155/2022/4127293.

Viscotrabeculotomy with anterior chamber irrigation versus Ahmed glaucoma valve implantation for silicone oil glaucoma in the pseudophakic eye.

Elwehidy A, Bayoumi N, Abdelkader A, Badawi A Arq Bras Oftalmol. 2022; 86(3):223-231.

PMID: 35319653 PMC: 11826558. DOI: 10.5935/0004-2749.20230042.

References

Sun J, Liang H, An M, Wang D . Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma. Int J Ophthalmol. 2017; 10(3):400-405. PMC: 5360775. DOI: 10.18240/IJO.2017.03.12. View

Hong Y, Hu Y, Dou H, Wang C, Zhang C, Ma Z . Comparison of the safety and efficacy of triple sequential therapy and transscleral cyclophotocoagulation for neovascular glaucoma in the angle-closure stage. Sci Rep. 2018; 8(1):7074. PMC: 5935688. DOI: 10.1038/s41598-018-25394-9. View

Yildirim N, Yalvac I, Sahin A, Ozer A, Bozca T . A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. J Glaucoma. 2009; 18(3):192-6. DOI: 10.1097/IJG.0b013e31817d235c. View

Dong Z, Gong J, Liao R, Xu S . Effectiveness of multiple therapeutic strategies in neovascular glaucoma patients: A PRISMA-compliant network meta-analysis. Medicine (Baltimore). 2018; 97(14):e9897. PMC: 5902299. DOI: 10.1097/MD.0000000000009897. View

William A, Spitzer M, Doycheva D, Dimopoulos S, Leitritz M, Voykov B . Comparison of ab externo trabeculotomy in primary open-angle glaucoma and uveitic glaucoma: long-term outcomes. Clin Ophthalmol. 2016; 10:929-34. PMC: 4883803. DOI: 10.2147/OPTH.S102414. View

WEISS D, SHAFFER R, NEHRENBERG T . Neovascular gluacoma complicating carotid-cavernous fistula. Arch Ophthalmol. 1963; 69:304-7. DOI: 10.1001/archopht.1963.00960040310007. View

Kim K, Suh W . Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice. Invest Ophthalmol Vis Sci. 2017; 58(9):3592-3599. DOI: 10.1167/iovs.17-21416. View

ElSheikha O, Abdelhakim M, Elhilali H, Kassem R . Is viscotrabeculotomy superior to conventional trabeculotomy in the management of Egyptian infants with congenital glaucoma?. Acta Ophthalmol. 2015; 93(5):e366-e371. DOI: 10.1111/aos.12634. View

Noor N, Mustafa S, Artini W . Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience. Clin Ophthalmol. 2017; 11:1417-1422. PMC: 5557098. DOI: 10.2147/OPTH.S137470. View

10.

Kokubun T, Tsuda S, Kunikata H, Himori N, Yokoyama Y, Omodaka K . Prediction of Surgical Outcome After Trabeculectomy for Neovascular Glaucoma With Anterior-segment Optical Coherence Tomography. J Glaucoma. 2018; 27(12):1157-1164. DOI: 10.1097/IJG.0000000000001081. View

11.

Tailor R, Kinsella M, Clarke J . Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma. Semin Ophthalmol. 2017; 33(5):606-612. DOI: 10.1080/08820538.2017.1375123. View

12.

Alkawas A, Shahien E, Hussein A . Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. J Glaucoma. 2010; 19(9):622-6. DOI: 10.1097/IJG.0b013e3181ccb794. View

13.

Villacampa P, Menger K, Abelleira L, Ribeiro J, Duran Y, Smith A . Accelerated oxygen-induced retinopathy is a reliable model of ischemia-induced retinal neovascularization. PLoS One. 2017; 12(6):e0179759. PMC: 5484470. DOI: 10.1371/journal.pone.0179759. View

14.

Wang M, Li Q, Dong H, Dong S, Li Y, Zheng C . Ahmed Valves vs Trabeculectomy Combined with Pans Plana Vitrectomy for Neovascular Glaucoma with Vitreous Hemorrhage. Eur J Ophthalmol. 2017; 27(6):774-780. PMC: 6380088. DOI: 10.5301/ejo.5000973. View

15.

Shinohara Y, Akiyama H, Magori M, Kishi S . Short-term outcomes after EX-PRESS implantation versus trabeculectomy alone in patients with neovascular glaucoma. Clin Ophthalmol. 2017; 11:2207-2213. PMC: 5734226. DOI: 10.2147/OPTH.S151200. View

16.

Fong A, Lee G, ORourke P, Thomas R . Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab. Clin Exp Ophthalmol. 2010; 39(4):318-23. DOI: 10.1111/j.1442-9071.2010.02449.x. View

17.

Zhao X, Wang Z, Yang X . Management of neovascular glaucoma with intravitreal ranibizumab, panretinal photocoagulation, and subsequent 5-fluorouracil augmented trabeculectomy: A case report. Medicine (Baltimore). 2017; 96(25):e7221. PMC: 5484223. DOI: 10.1097/MD.0000000000007221. View